Ann: AACC conference summary and CEO interview, page-15

I remember that Qiagen bought out another biotech I invested in years ago called Cellestis (CST.AX) Working from memory, and a discussion with Shane at the March lab visit, some of our ADO team worked for Cellestis. I was not happy as an investor when the board recommended accepting the offer, which had to be increased from the original proposal. Qiagen has had a dramatic increased in share price since taking over little Aussie CST.AX. There are old CST threads on HC if anyone is interested in revisiting the past.

cheers,

hippies